Total Payments
$6,198
2024 Payments
$372.68
Companies
19
Transactions
277
Medicare Patients
4,930
Medicare Billing
$895,586
Payment Breakdown by Category
Food & Beverage$6,167 (99.5%)
Education$31.10 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,167 | 272 | 99.5% |
| Education | $31.10 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,859 | 70 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $601.31 | 24 | $0 (2021) |
| PFIZER INC. | $516.14 | 29 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $462.94 | 9 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $453.44 | 30 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $264.40 | 15 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $261.81 | 11 | $0 (2020) |
| ARBOR PHARMACEUTICALS, INC. | $256.99 | 17 | $0 (2019) |
| Novo Nordisk Inc | $238.31 | 13 | $0 (2022) |
| Lilly USA, LLC | $228.10 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $372.68 | 8 | AstraZeneca Pharmaceuticals LP ($147.37) |
| 2023 | $448.32 | 13 | AstraZeneca Pharmaceuticals LP ($242.54) |
| 2022 | $507.95 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($225.78) |
| 2021 | $486.83 | 26 | PFIZER INC. ($172.82) |
| 2020 | $549.60 | 30 | AstraZeneca Pharmaceuticals LP ($266.39) |
| 2019 | $814.53 | 40 | AstraZeneca Pharmaceuticals LP ($217.79) |
| 2018 | $1,106 | 58 | AstraZeneca Pharmaceuticals LP ($403.58) |
| 2017 | $1,911 | 94 | AstraZeneca Pharmaceuticals LP ($381.08) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $32.32 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $119.90 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: RESPIRATORY | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: Respiratory | ||||||
| 05/16/2024 | Lilly USA, LLC | JAYPIRCA (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Oncology | ||||||
| 04/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/21/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 11/06/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/30/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/23/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/07/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Diabetes | ||||||
| 04/24/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $108.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $103.58 | General |
| Category: DIABETES | ||||||
| 09/28/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/14/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $97.84 | General |
| Category: Cardio-renal | ||||||
| 09/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $122.20 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,041 | 2,845 | $487,155 | $253,266 |
| 2022 | 18 | 1,288 | 2,977 | $497,620 | $236,726 |
| 2021 | 19 | 1,285 | 2,685 | $440,380 | $213,660 |
| 2020 | 22 | 1,316 | 2,607 | $341,935 | $191,933 |
Total Patients
4,930
Total Services
11,114
Medicare Billing
$895,586
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 95 | 1,135 | $187,275 | $110,865 | 59.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 158 | 408 | $61,200 | $30,506 | 49.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 308 | $61,600 | $22,774 | 37.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 187 | $42,075 | $20,951 | 49.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 126 | 126 | $25,200 | $19,211 | 76.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 33 | 113 | $28,250 | $12,562 | 44.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 42 | 63 | $22,050 | $10,202 | 46.3% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 25 | 40 | $8,000 | $5,722 | 71.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 41 | 57 | $12,825 | $4,314 | 33.6% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 19 | 22 | $5,500 | $3,760 | 68.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 25 | 39 | $4,875 | $2,728 | 56.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 72 | 72 | $3,960 | $2,555 | 64.5% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 71 | 71 | $3,905 | $2,342 | 60.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 159 | 179 | $15,215 | $2,058 | 13.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,600 | $1,727 | 48.0% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 12 | 13 | $1,625 | $988.39 | 60.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 116 | 951 | $156,915 | $78,466 | 50.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 183 | 512 | $76,800 | $39,085 | 50.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 326 | $65,200 | $22,089 | 33.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 128 | 128 | $25,600 | $19,914 | 77.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 72 | $25,200 | $13,499 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 82 | $18,450 | $9,310 | 50.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 56 | 60 | $15,000 | $8,915 | 59.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 63 | 141 | $17,625 | $8,850 | 50.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 84 | $21,000 | $8,223 | 39.2% |
About Dr. H Bianca Japal, M.D
Dr. H Bianca Japal, M.D is a Internal Medicine healthcare provider based in Uniondale, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194724294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. H Bianca Japal, M.D has received a total of $6,198 in payments from pharmaceutical and medical device companies, with $372.68 received in 2024. These payments were reported across 277 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($6,167).
As a Medicare-enrolled provider, Japal has provided services to 4,930 Medicare beneficiaries, totaling 11,114 services with total Medicare billing of $895,586. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Uniondale, NY
- Active Since 07/20/2005
- Last Updated 03/16/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1194724294
Products in Payments
- FARXIGA (Drug) $1,510
- JARDIANCE (Drug) $442.69
- JANUVIA (Drug) $385.67
- XARELTO (Drug) $355.53
- ELIQUIS (Drug) $304.30
- CHANTIX (Drug) $249.58
- ENTRESTO (Drug) $244.81
- TOUJEO (Drug) $215.33
- Edarbi (Drug) $200.90
- APTIOM (Drug) $175.70
- Victoza (Drug) $153.49
- AIRSUPRA (Drug) $129.45
- SYMBICORT (Drug) $126.92
- LINZESS (Drug) $126.05
- ADVAIR (Drug) $125.11
- JAYPIRCA (Drug) $124.99
- BELSOMRA (Drug) $102.82
- Kerendia (Drug) $97.84
- INVOKANA (Drug) $91.89
- Ozempic (Drug) $84.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Uniondale
Dr. Marcia Naveh, Md, MD
Internal Medicine — Payments: $65,000
Internal Medicine $65,000
Rama Raju, Md, MD
Internal Medicine — Payments: $6,416
Internal Medicine $6,416
Dr. Umair Nasir, Do, DO
Internal Medicine — Payments: $883.41
Internal Medicine $883.41
Cassandra Sanossian, Md, Rd, MD, RD
Internal Medicine — Payments: $421.34
Internal Medicine $421.34
Monica David, M.d, M.D
Internal Medicine — Payments: $15.72
Internal Medicine $15.72